降糖药与2型糖尿病的线粒体动力学及研究现状
Mitochondrial Dynamics and Research Status of Hypoglycemic Drugs and Type 2 Diabetes Mellitus
DOI: 10.12677/jcpm.2024.32033, PDF,    科研立项经费支持
作者: 屈 颖：青海大学研究生院，青海 西宁；罗 玮*：青海省人民医院内分泌科，青海 西宁
关键词: 线粒体动力学；2型糖尿病；降糖药；Mitochondrial Dynamics； Type 2 Diabetes Mellitus； Hypoglycemic Drugs
摘要: 线粒体作为大多数细胞生存的重要细胞器，在细胞能量代谢的过程当中起着十分重要的作用。在2型糖尿病(Type 2 Diabetes Mellitus, T2DM)作用机制中，尚未明确线粒体动力学功能障碍究竟扮演什么样的角色，是触发因素还是结局指标。随着对线粒体功能的研究深入，发现二甲双胍、恩格列净类、利拉鲁肽类等药物在T2DM治疗当中可能抑制线粒体动力学裂变，改善线粒体功能障碍，在此作一简单综述，为之后线粒体动力学在T2DM治疗当中的研究提供一可能的思路方向。
Abstract: Mitochondria, as an important organelle for most cell survival, play a very important role in the process of cell energy metabolism. In the mechanism of type 2 diabetes mellitus (T2DM), it is not clear what role mitochondrial dynamics dysfunction plays, whether it is a trigger or an outcome indicator. With the in-depth study of mitochondrial function, it has been found that metformin, empagliflozin, liraglutide and other drugs may inhibit mitochondrial dynamics fission and improve mitochondrial dysfunction in the treatment of T2DM. This paper makes a brief review, which provides a possible direction for the study of mitochondrial dynamics in the treatment of T2DM.
文章引用：屈颖, 罗玮. 降糖药与2型糖尿病的线粒体动力学及研究现状[J]. 临床个性化医学, 2024, 3(2): 223-228. https://doi.org/10.12677/jcpm.2024.32033

参考文献

[1] Gao, S., Zhang, Y., Liang, K., et al. (2022) Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes. Stem Cells International, 2022, Article ID: 8637493. [Google Scholar] [CrossRef] [PubMed]
[2] Postler, T.S., Peng, V., Bhatt, D.M., et al. (2021) Metformin Selectively Dampens the Acute Inflammatory Response through an AMPK-Dependent Mechanism. Scientific Reports, 11, Article No. 18721. [Google Scholar] [CrossRef] [PubMed]
[3] 杨雁, 余学锋. 从指南更新看二甲双胍在2型糖尿病药物治疗中的地位[J]. 中国实用内科杂志, 2022, 42(11): 884-888.
[4] Lee, H.J., Chae, C.W. and Han, H.J. (2023) Enhancing the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in Diabetes: Amelioration of Mitochondrial Dysfunction-Induced Senescence. Biomedicine & Pharmacotherapy, 168, Article ID: 115759. [Google Scholar] [CrossRef] [PubMed]
[5] Prasun, P. (2020) Mitochondrial Dysfunction in Metabolic Syndrome. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1866, Article ID: 165838. [Google Scholar] [CrossRef] [PubMed]
[6] Holmstrom, M.H., Iglesias-Gutierrez, E., Zierath, J.R., et al. (2012) Tissue-Specific Control of Mitochondrial Respiration in Obesity-Related Insulin Resistance and Diabetes. American Journal of Physiology-Endocrinology and Metabolism, 302, E731-E739. [Google Scholar] [CrossRef] [PubMed]
[7] Shan, Z., Fa, W.H., Tian, C.R., et al. (2022) Mitophagy and Mitochondrial Dynamics in Type 2 Diabetes Mellitus Treatment. Aging, 14, 2902-2919. [Google Scholar] [CrossRef] [PubMed]
[8] Yu, T., Wang, L., Zhang, L., et al. (2023) Mitochondrial Fission as a Therapeutic Target for Metabolic Diseases: Insights into Antioxidant Strategies. Antioxidants, 12, Article 1163. [Google Scholar] [CrossRef] [PubMed]
[9] Ma, Y., Zhou, X., Gui, M., et al. (2023) Mitophagy in Hypertension-Mediated Organ Damage. Frontiers in Cardiovascular Medicine, 10, Article 1309863. [Google Scholar] [CrossRef] [PubMed]
[10] Barazzuol, L., Giamogante, F., Brini, M., et al. (2020) PINK1/Parkin Mediated Mitophagy, Ca2 Signalling, and ER-Mitochondria Contacts in Parkinson’s Disease. International Journal of Molecular Sciences, 21, Article 1772. [Google Scholar] [CrossRef] [PubMed]
[11] Yoon, Y.G., Haug, C.L. and Koob, M.D. (2007) Interspecies Mitochondrial Fusion between Mouse and Human Mitochondria Is Rapid and Efficient. Mitochondrion, 7, 223-229. [Google Scholar] [CrossRef] [PubMed]
[12] Chandhok, G., Lazarou, M. and Neumann, B. (2018) Structure, Function, and Regulation of Mitofusin-2 in Health and Disease. Biological Reviews, 93, 933-949. [Google Scholar] [CrossRef] [PubMed]
[13] Alexander, C., Votruba, M., Pesch, U.E., et al. (2000) OPA1, Encoding a Dynamin-Related GTPase, Is Mutated in Autosomal Dominant Optic Atrophy Linked to Chromosome 3q28. Nature Genetics, 26, 211-215. [Google Scholar] [CrossRef] [PubMed]
[14] Mishra, P. and Chan, D.C. (2016) Metabolic Regulation of Mitochondrial Dynamics. Journal of Cell Biology, 212, 379-387. [Google Scholar] [CrossRef] [PubMed]
[15] 郝希纯, 王东明. Drp1蛋白调节线粒体分裂机制及其在疾病中的作用[J]. 广东医学, 2011, 32(8): 1066-1069.
[16] Forrester, S.J., Preston, K.J., Cooper, H.A., et al. (2020) Mitochondrial Fission Mediates Endothelial Inflammation. Hypertension, 76, 267-276. [Google Scholar] [CrossRef] 
[17] Imoto, Y., Itoh, K. and Fujiki, Y. (2020) Molecular Basis of Mitochondrial and Peroxisomal Division Machineries. International Journal of Molecular Sciences, 21, Article 5452. [Google Scholar] [CrossRef] [PubMed]
[18] Breitzig, M.T., Alleyn, M.D., Lockey, R.F., et al. (2018) A Mitochondrial Delicacy: Dynamin-Related Protein 1 and Mitochondrial Dynamics. American Journal of Physiology-Cell Physiology, 315, C80-C90. [Google Scholar] [CrossRef] [PubMed]
[19] Protasoni, M. and Zeviani, M. (2021) Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions. International Journal of Molecular Sciences, 22, Article 586. [Google Scholar] [CrossRef] [PubMed]
[20] Yu, Y., Peng, X.D., Qian, X.J., et al. (2021) Fis1 Phosphorylation by Met Promotes Mitochondrial Fission and Hepatocellular Carcinoma Metastasis. Signal Transduction and Targeted Therapy, 6, Article No. 401. [Google Scholar] [CrossRef] [PubMed]
[21] 陈立, 关凤英, 于洋. 线粒体动力学与2型糖尿病和糖尿病并发症关系的研究进展[J]. 中国药理学与毒理学杂志, 2015, 29(3): 339-347.
[22] Van Huynh, T., Rethi, L., Rethi, L., et al. (2023) The Complex Interplay between Imbalanced Mitochondrial Dynamics and Metabolic Disorders in Type 2 Diabetes. Cells, 12, Article 1223. [Google Scholar] [CrossRef] [PubMed]
[23] Lee, H. and Song, W. (2018) Exercise and Mitochondrial Remodeling in Skeletal Muscle in Type 2 Diabetes. Journal of Obesity & Metabolic Syndrome, 27, 150-157. [Google Scholar] [CrossRef] [PubMed]
[24] Zorzano, A., Liesa, M. and Palacin, M. (2009) Role of Mitochondrial Dynamics Proteins in the Pathophysiology of Obesity and Type 2 Diabetes. The International Journal of Biochemistry & Cell Biology, 41, 1846-1854. [Google Scholar] [CrossRef] [PubMed]
[25] Lin, H.Y., Weng, S.W., Chang, Y.H., et al. (2018) The Causal Role of Mitochondrial Dynamics in Regulating Insulin Resistance in Diabetes: Link through Mitochondrial Reactive Oxygen Species. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 7514383. [Google Scholar] [CrossRef] [PubMed]
[26] De Maranon, A.M., Canet, F., Abad-Jimenez, Z., et al. (2021) Does Metformin Modulate Mitochondrial Dynamics and Function in Type 2 Diabetic Patients? Antioxidants & Redox Signaling, 35, 377-385. [Google Scholar] [CrossRef] [PubMed]
[27] Kang, H., Khang, R., Ham, S., et al. (2017) Activation of the ATF2/CREB-PGC-1α Pathway by Metformin Leads to Dopaminergic Neuroprotection. Oncotarget, 8, 48603-48618. [Google Scholar] [CrossRef] [PubMed]
[28] Palee, S., Higgins, L., Leech, T., et al. (2020) Acute Metformin Treatment Provides Cardioprotection via Improved Mitochondrial Function in Cardiac Ischemia/Reperfusion Injury. Biomedicine & Pharmacotherapy, 130, Article ID: 110604. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, H., Wang, S., Zhu, P., et al. (2018) Empagliflozin Rescues Diabetic Myocardial Microvascular Injury via AMPK-Mediated Inhibition of Mitochondrial Fission. Redox Biology, 15, 335-346. [Google Scholar] [CrossRef] [PubMed]
[30] Koizumi, T., Watanabe, M., Yokota, T., et al. (2023) Empagliflozin Suppresses Mitochondrial Reactive Oxygen Species Generation and Mitigates the Inducibility of Atrial Fibrillation in Diabetic Rats. Frontiers in Cardiovascular Medicine, 10, Article 1005408. [Google Scholar] [CrossRef] [PubMed]
[31] Torres, G., Morales, P.E., Garcia-Miguel, M., et al. (2016) Glucagon-Like Peptide-1 Inhibits Vascular Smooth Muscle Cell Dedifferentiation through Mitochondrial Dynamics Regulation. Biochemical Pharmacology, 104, 52-61. [Google Scholar] [CrossRef] [PubMed]